新希望(000876.SZ):擬以老股收購及增資取得漳州紅杉生物科技80%股權
格隆匯6月22日丨新希望(000876.SZ)公佈,公司第八屆董事會第三十九次會議決議,審議通過了“關於收購漳州紅杉生物科技有限公司80%股權的議案”;
根據公司飼料產業發展需要,為實現福建空白市場佈局突破,公司擬通過老股收購及增資方式取得漳州紅杉生物科技有限公司80%股權,收購價款總計為4470.4萬元。漳州紅杉合法擁有以下資產:
(1)位於靖城鎮,合計面積為24598平方米的國有建設用地使用權。
(2)在上述國有建設用地上合法建設的飼料廠及其所涉土建、鋼構、設備、廠內道路等(在建)工程及固定資產、實物等;
(3)產品研發體系及技術體系、目標公司原經營管理團隊、客户網絡及經銷商渠道及飼料業務現有的穩定市場份額。
(4)已取得國有建設土地、建設項目、飼料經營各項審批手續,以及環評、安評、消防等批覆和驗收等合規手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.